Psilocybin and hallucinogenic mushrooms.

IF 3.4 3区医学 Q2 CLINICAL NEUROLOGY

CNS Spectrums Pub Date : 2024-12-01 Epub Date: 2025-01-10 DOI:10.1017/S1092852924002487

Mathieu Fradet, Carlton M Kelly, Anna J Donnelly, Trisha Suppes

引用次数: 0

Abstract

Psilocybin therapy has recently emerged as a promising new treatment for depression and other mental health disorders. This chapter summarizes the most recent data on its safety and efficacy. The delivery of psilocybin therapy and its subjective effects are also presented. Furthermore, this chapter outlines our current understanding of psilocybin's pharmacology and neurobiological effects. Other similar psychedelic substances with encouraging therapeutic potential are briefly presented.

查看原文本刊更多论文

裸盖菇素和致幻蘑菇。

裸盖菇素疗法最近成为治疗抑郁症和其他精神疾病的一种很有前景的新疗法。本章总结了其安全性和有效性的最新数据。还介绍了裸盖菇素治疗的递送及其主观效应。此外，本章概述了我们目前对裸盖菇素的药理学和神经生物学作用的了解。简要介绍了其他具有令人鼓舞的治疗潜力的类似致幻剂。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CNS Spectrums 医学-精神病学

CiteScore

6.20

自引率

6.10%

发文量

239

审稿时长

>12 weeks

期刊介绍： CNS Spectrums covers all aspects of the clinical neurosciences, neurotherapeutics, and neuropsychopharmacology, particularly those pertinent to the clinician and clinical investigator. The journal features focused, in-depth reviews, perspectives, and original research articles. New therapeutics of all types in psychiatry, mental health, and neurology are emphasized, especially first in man studies, proof of concept studies, and translational basic neuroscience studies. Subject coverage spans the full spectrum of neuropsychiatry, focusing on those crossing traditional boundaries between neurology and psychiatry.